• Rainer Lichtenberger, Ph.D. MBA

    More than 30 years management in life science Industry, EVP Merckle/ratiopharm group for BD; Since 16 years CEO/COO experience in several SME, raised € 80 Mn venture funds.

    Read more
  • Christian Wallasch, Ph.D.

    Seasoned executive management member (COO, CEO) in biopharmaceuticals SME, as Axxima and U3, as well as public companies like Intercell/Valneva. Expert in kinase inhibitors, vaccines development, project management and execution.

    Read more
  • Olaf Althaus

    20 years of Biotech industry, active as entrepreneur, manager, deal maker, Co-founder, CEO and CFO of CellMed AG, MD of AEterna Zentaris, 10 years Private Equity & M&A-Advisory

    Read more
  • Stephan Stenglein, M.D.

    Physician trained in Clinical and Molecular Virology with 20 years of accomplishments in pharma, medical device and vaccine development. Previous global management positions with Novartis and AstraZeneca.

    Read more
  • Prof. Oliver Planz, Ph.D.

    Universität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.

    Read more
  • Björn Cochlovius, Ph.D., Assoc. Prof.
    VP Business Development

    20 years leadership positions in SMEs (Head R&D Affitech, CEO OnTarget) and big pharma (Roche, Otsuka, Abbvie). Working experiences in Europe and Asia. Background in R&D, Business Development, M&A, Financing

    Read more
  • 1


Atriva Therapeutics GmbH
Eisenbahnstr. 1, 72072 Tübingen

+49 (0)7071 8597673


In order to be able to design our website in the best possible way and to continuously improve it, we are using cookies. By continuing to use our website, you permit the use of cookies. More information can be found in our data protection rules.